Paydirt
ARTV
Ticker

Artiva Biotherapeutics, Inc.

ARTV · Healthcare · Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for pa…

Artiva Biotherapeutics, Inc. (ARTV), in the Healthcare sector, has 15 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 10 purchases and 5 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 9. The most active filer was Ra Capital Management, L.P. with 9 filings.

Add to watchlist
Filings, ttm
15
10 buys · 5 sells · 1 late
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$110.4M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 8
Filed Sep 9
ADViAverage daily dollar volume
$6.3M
market data
Share price · 12M
$8.91 (+230.0%)
$13.39$7.99$2.59Sep 22 2025Mar 19Sep 15

Adjusted for splits and dividends.

Volume by month
$91.5M$45.7M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2025 · sells $153KMay 2026 · buys $91.5MMay 2026 · sells $244KJun 2026 · buys $12.5MJul 2026 · buys $4.9MSep 2026 · sells $1.1M
Buys $109.0M Sells $1.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
RP Ra Capital Management, L.P. Director 9 filings FA Fred Aslan President and CEO 4 filings GC GC Corp. 10% owner 1 filing CH Christopher Horan Chief Tech Operations Officer 1 filing
Recent filings
Fred AslanSALE Chief Executive Officer $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET
Christopher HoranSALE Chief Tech Operations Officer $116K
10,366 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:04 PM ET
Fred AslanSALE Chief Executive Officer $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET
Ra Capital Management, L.P.PURCHASE Director $456K
45,768 sh across 2 lots
Exec Jul 29
Filed Jul 31 · 5:13 PM ET
Ra Capital Management, L.P.PURCHASE Director $413K
41,319 sh × $9.99
Exec Jul 24
Filed Jul 28 · 5:24 PM ET
Ra Capital Management, L.P.PURCHASE Director $2.6M
264,586 sh across 3 lots
Exec Jul 21
Filed Jul 23 · 9:22 PM ET
Ra Capital Management, L.P.PURCHASE Director $1.4M
152,472 sh × $8.93
Exec Jul 16
Filed Jul 20 · 6:08 PM ET
Ra Capital Management, L.P.PURCHASE Director $135K
15,102 sh × $8.97
Exec Jul 10
Filed Jul 14 · 7:00 PM ET
Ra Capital Management, L.P.PURCHASE Director $275K
31,000 sh × $8.88
Exec Jun 25
Filed Jun 29 · 4:20 PM ET
Ra Capital Management, L.P.PURCHASE Director $4.6M
531,326 sh across 3 lots
Exec Jun 12
Filed Jun 16 · 6:08 PM ET
Ra Capital Management, L.P.PURCHASE Director $7.6M
1,027,619 sh across 2 lots
Exec Jun 9
Filed Jun 11 · 7:36 PM ET
GC Corp.PURCHASE 10% owner $16.5M
1,432,291 sh across 2 lots
Exec May 11
Filed May 28 · 4:34 PM ET †
Fred AslanSALE Chief Executive Officer $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET
Ra Capital Management, L.P.PURCHASE Director $75.0M
6,510,416 sh × $11.52
Exec May 11
Filed May 13 · 5:45 PM ET
Fred AslanSALE President and CEO $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET